Marathon Trading Investment Management’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.18K Hold
32,888
﹤0.01% 269
2025
Q4
$1.28K Hold
32,888
﹤0.01% 330
2025
Q3
$1.24K Hold
32,888
﹤0.01% 292
2025
Q2
$1.16K Hold
32,888
﹤0.01% 264
2025
Q1
$1.08K Hold
32,888
﹤0.01% 342
2024
Q4
$1.6K Hold
32,888
﹤0.01% 305
2024
Q3
$2.14K Hold
32,888
﹤0.01% 259
2024
Q2
$1.64K Hold
32,888
﹤0.01% 284
2024
Q1
$3.45K Hold
32,888
﹤0.01% 337
2023
Q4
$658 Hold
32,888
﹤0.01% 361
2023
Q3
$2.79K Hold
32,888
﹤0.01% 317
2023
Q2
$1.43K Hold
32,888
﹤0.01% 254
2023
Q1
$1.02K Hold
32,888
﹤0.01% 265
2022
Q4
$1.25K Hold
32,888
﹤0.01% 270
2022
Q3
$1K Hold
32,888
﹤0.01% 276
2022
Q2
$4K Hold
32,888
﹤0.01% 281
2022
Q1
$8K Hold
32,888
﹤0.01% 310
2021
Q4
$25K Hold
32,888
﹤0.01% 287
2021
Q3
$21K Buy
+32,888
New +$26.7K ﹤0.01% 362

Other funds holding COCHW

Marathon Trading Investment Management's COCHW Position: Q1 2026 in Review

Marathon Trading Investment Management held its Envoy Medical Warrant (COCHW) position steady in Q1 2026 at 32,888 shares worth $2.18K. The position accounts for ﹤0.01% of the portfolio, ranked #269.

Marathon Trading Investment Management first reported a position in COCHW in Q3 2021 and has held it in 19 quarters since. The position peaked at $25K in Q4 2021. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • Marathon Trading Investment Management held 32,888 shares of Envoy Medical Warrant worth $2.18K as of Q1 2026.
  • Marathon Trading Investment Management left its Envoy Medical Warrant share count unchanged in Q1 2026.
  • Envoy Medical Warrant made up ﹤0.01% of Marathon Trading Investment Management's portfolio in Q1 2026, its #269 holding.
  • Marathon Trading Investment Management first reported a position in Envoy Medical Warrant in Q3 2021 and has held it in 19 quarters since.
  • Marathon Trading Investment Management's Envoy Medical Warrant position peaked at $25K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Marathon Trading Investment Management's 13F filing for Q1 2026, filed 14 May 2026.